Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | MMP1 | P03956 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | MMP9 | P14780 | 1/20 | 0.30 |
| ▸ | MMP8 | P22894 | 1/20 | 0.30 |
| ▸ | MMP13 | P45452 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8617976 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL63212 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL62768 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL6906534 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL8614275 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL3133329 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL62965 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL4123177 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL17997086 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL4265800 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109054795-B | Preparation method of hybrid fluorine-containing surfactant for ultra-low permeability reservoir flooding | 成都理工大学 | 2020-10-13 | — | — | CN | disclosed |
| US-9879153-B2 | Anti-icing composite | WANG LIANG (US) | 2018-01-30 | — | — | US | disclosed |
| EP-2096099-B1 | Purification of fluorinated alcohols | DU PONT (US) | 2016-04-13 | — | — | EP | disclosed |
| US-20160009971-A1 | Anti-Icing Composite | WANG LIANG (US) | 2016-01-14 | — | — | US | disclosed |
| US-20150110814-A1 | COMBINATION THERAPIES WITH PSMA LIGAND CONJUGATES | PSMA DEVELOPMENT COMPANY, LLC (US) | 2015-04-23 | — | — | US | disclosed |
| EP-1807382-B1 | PURIFICATION OF FLUORINATED ALCOHOLS | DU PONT (US) | 2011-12-21 | — | — | EP | disclosed |
| EP-2096099-A1 | Purification of fluorinated alcohols | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-09-02 | — | — | EP | disclosed |
| US-7138551-B2 | Purification of fluorinated alcohols | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2006-11-21 | — | — | US | disclosed |
| US-20060100464-A1 | Purification of fluorinated alcohols | THE CHEMOURS COMPANY FC, LLC | 2006-05-11 | — | — | US | disclosed |
| US-6002048-A | Fluorine-containing ether compound and gelling agent containing the same | KAO CORPORATION (JP) | 1999-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150110814-A1 | COMBINATION THERAPIES WITH PSMA LIGAND CONJUGATES | CD47, CD4, PSMA1 | LMNA 4423/4885THRB 1918/4885CA1 25/4885 |
| US-20060100464-A1 | Purification of fluorinated alcohols | ADH1A, ADH1C, ADH5 | LMNA 1163/4885THRB 85/4885CA1 495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.